Sorbye H, Hjortland GO, Vestermark LW, Ladekarl M, Svensson J, Sundlöv A, Janson ET, Garresori H, Hofsli E, Kersten C, Elvebakken H, Pfeiffer P, Morken S, Assmus J, Lothe IMB, Tabaksblat E, Knigge U, Couvelard A, Perren A, Langer SW (2025)
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer (in press)
DOI 10.1038/s41416-025-03095-1, PubMed 40659859

Skipar K, Ørvik MS, Evers C, Balteskard L, Ekanger C, Giske LE, Ødegaard K, Østrem EH, Nordstrand CS, Tøndel H, Nieder C, Guren MG, Kaasa S, Ragnum HB (2025)
Palliative radiotherapy in symptomatic pelvic soft tissue tumors (PallSoft)- protocol for a national, randomized, non-inferiority study
BMC Cancer, 25 (1), 1051
DOI 10.1186/s12885-025-14424-1, PubMed 40597814

Ericson J, Klevebro F, Sunde B, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Lorentzen SS, Slott M, Schröder W, Rouvelas I, Nilsson M (2025)
Nutritional outcomes and impact of malnutrition in a randomised comparison between standard and prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer
Eur J Surg Oncol, 51 (9), 110228 (in press)
DOI 10.1016/j.ejso.2025.110228, PubMed 40550184